1. Home
  2. Labeler Index
  3. Teva Pharmaceuticals, Inc.
  4. 0480-7250
  5. NDC Package Code: 0480-7250-46 Liraglutide

NDC Package 0480-7250-46 Liraglutide

Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0480-7250-46
Package Description:
5 SYRINGE, PLASTIC in 1 CARTON / 3 mL in 1 SYRINGE, PLASTIC
Product Code:
0480-7250
Proprietary Name:
Liraglutide
Non-Proprietary Name:
Liraglutide
Substance Name:
Liraglutide
Usage Information:
This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.
11-Digit NDC Billing Format:
00480725046
Product Type:
Human Prescription Drug
Labeler Name:
Teva Pharmaceuticals, Inc.
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
LIRAGLUTIDE 6 mg/mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA214568
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
08-28-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0480-7250-46?

The NDC Packaged Code 0480-7250-46 is assigned to a package of 5 syringe, plastic in 1 carton / 3 ml in 1 syringe, plastic of Liraglutide, a human prescription drug labeled by Teva Pharmaceuticals, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.

Is NDC 0480-7250 included in the NDC Directory?

Yes, Liraglutide with product code 0480-7250 is active and included in the NDC Directory. The product was first marketed by Teva Pharmaceuticals, Inc. on August 28, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 0480-7250-46?

The 11-digit format is 00480725046. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20480-7250-465-4-200480-7250-46